Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-3 of 3
Keywords: Spironolactone
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Canrenone and Androgen Receptor-Active Materials in Plasma of Cirrhotic Patients during Long-Term K-Canrenoate or Spironolactone Therapy
Available to PurchaseSubject Area:
Gastroenterology
Journal:
Digestion
Digestion (1989) 44 (3): 155–162.
Published Online: 03 February 2009
...A. Andriulli; A. Arrigoni; T. Gindro; I. Karbowiak; G. Buzzetti; D. Armanini Plasma levels of canrenone and androgen receptor-active materials (ARM) were determined during long-term oral K-canrenoate or spironolactone therapy in cirrhotics with chronic recurrent ascites. Mean plasma canrenone level...
Journal Articles
Bumetanide, Spironolactone and a Combination of the Two, in the Treatment of Ascites due to Liver Disease: A Prospective, Controlled, Randomized Trial
Available to PurchaseSubject Area:
Gastroenterology
Journal:
Digestion
Digestion (1988) 41 (2): 101–107.
Published Online: 30 January 2009
... patients with ascites were randomly allocated to receive for 2 weeks bumetanide (group A, n = 13), spironolactone (group B, n = 12) or a combination of the two drugs (group C, n = 12) after a 5-day stabilization period. The response to the treatment was 69, 42 and 83% in groups A, B and C, respectively...
Journal Articles
Importance of Plasma Aldosterone Concentration on the Natriuretic Effect of Spironolactone in Patients with Liver Cirrhosis and Ascites
Available to PurchaseSubject Area:
Gastroenterology
Journal:
Digestion
Digestion (1985) 31 (4): 189–193.
Published Online: 28 January 2009
... investigated. The dosage of spironolactone needed to induce a negative sodium balance correlated significantly with plasma aldosterone concentration: r = 0.64; p < 0.001. However, in cases with plasma albumin concentration < 3 g/dl, glomerular filtration rate < 80 ml/min, and plasma sodium...